An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants

Hoffmann-La Roche134 enrolled

Overview

This multi-center, observational study involves reviewing the medical records of approximately 100 adult participants diagnosed with advanced BCC from 01 January 2005 until 31 December 2010. Participant records will be analyzed to identify participant characteristics, treatment patterns and clinical outcomes.

Study Type

OBSERVATIONAL

Enrollment

134

Conditions

Basal Cell Carcinoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * New diagnosis of advanced BCC, defined as (1) locally advanced BCC (inoperable as determined by the site investigator or surgery contraindicated) with receipt of radiation therapy (unless radiation was contraindicated), or (2) metastatic BCC, from 01 January 2005 through 31 December 2010 Exclusion Criteria: * Participation in an interventional trial that dictated treatment during the study time period (01 January 2005 - 31 December 2010), or within 90 days prior to individual participant' study enrolment dates * Participants undergoing treatment with a Hedgehog pathway inhibitor

Locations (42)

Outcomes

Primary Outcomes

Participants Demographics: Age at Initation of Study

Time frame: Baseline (Initiation of the study)

Participants Demographics: Gender at Initation of Study

Time frame: Baseline

Participants Demographics: Race at Initation of Study

Time frame: Baseline

Participants Demographics: Country of Enrollment at Initation of Study

Time frame: Baseline

Percentage of Participants Categorized as per BCC Disease History